Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNA3 | P22001 | 1/20 | 0.43 |
| ▸ | HTR1B | P28222 | 4/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.40 |
| ▸ | CNR2 | P34972 | 4/20 | 0.39 |
| ▸ | HRH3 | Q9Y5N1 | 4/20 | 0.39 |
| ▸ | HTR2A | P28223 | 2/20 | 0.39 |
| ▸ | HTR7 | P34969 | 2/20 | 0.39 |
| ▸ | HTR6 | P50406 | 2/20 | 0.39 |
| ▸ | CNR1 | P21554 | 3/20 | 0.39 |
| ▸ | HRH1 | P35367 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.36 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12290140 | 0.88 | MAPT (0.36) | KCNA3HTR1BTDP1GAAL3MBTL1 | |
| SCHEMBL26071286 | 0.87 | KCNA3 (0.34) | KCNA3HTR1BTDP1GAAL3MBTL1 | |
| SCHEMBL655423 | 0.84 | CNR2 (0.43) | TDP1GAAL3MBTL1CNR2CNR1 | |
| SCHEMBL10019289 | 0.80 | RIPK1 (0.37) | SLC6A4 | |
| SCHEMBL652710 | 0.80 | MAPT (0.53) | CYP2C9 | |
| SCHEMBL654398 | 0.78 | ALDH1A1 (0.44) | TDP1GAASLC6A4 | |
| SCHEMBL21925267 | 0.76 | BRD4 (0.41) | TDP1GAASLC6A4CNR2HTR2A | |
| SCHEMBL22969288 | 0.75 | MEN1 (0.33) | TDP1GAACNR2HRH3HTR2A | |
| SCHEMBL6915133 | 0.74 | GAA (0.51) | KCNA3HTR1BTDP1GAAL3MBTL1 | |
| SCHEMBL7420976 | 0.74 | GAA (0.55) | HTR1BTDP1GAAL3MBTL1CNR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8530585-B2 | Crosslinker, crosslinked polymer material, and production method of the crosslinked polymer material | TOYODA GOSEI CO., LTD. (JP) | 2013-09-10 | — | — | US | claimed |
| US-20110224380-A1 | CROSSLINKER, CROSSLINKED POLYMER MATERIAL, AND PRODUCTION METHOD OF THE CROSSLINKED POLYMER MATERIAL | TOYODA GOSEI CO., LTD. (JP) | 2011-09-15 | — | — | US | claimed |
| US-8530585-B2 | Crosslinker, crosslinked polymer material, and production method of the crosslinked polymer material | TOYODA GOSEI CO., LTD. (JP) | 2013-09-10 | — | — | US | disclosed |
| US-8530585-B2 | Crosslinker, crosslinked polymer material, and production method of the crosslinked polymer material | TOYODA GOSEI CO., LTD. (JP) | 2013-09-10 | — | — | US | disclosed |
| US-20110224380-A1 | CROSSLINKER, CROSSLINKED POLYMER MATERIAL, AND PRODUCTION METHOD OF THE CROSSLINKED POLYMER MATERIAL | TOYODA GOSEI CO., LTD. (JP) | 2011-09-15 | — | — | US | disclosed |
| US-20110224380-A1 | CROSSLINKER, CROSSLINKED POLYMER MATERIAL, AND PRODUCTION METHOD OF THE CROSSLINKED POLYMER MATERIAL | TOYODA GOSEI CO., LTD. (JP) | 2011-09-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110224380-A1 | CROSSLINKER, CROSSLINKED POLYMER MATERIAL, AND PRODUCTION METHOD OF THE CROSSLINKED POLYMER MATERIAL | DUOX2, PPOX, NOXO1 | KCNA3 3749/4885HTR1B 4074/4885TDP1 1667/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.